证券代码：601577 证券简称：长沙银行 编号：2025-036 优先股代码：360038 优先股简称：长银优 1 长沙银行股份有限公司 关于股东部分股份解除质押及质押的公告 本行董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 长沙通程实业（集团）有限公司（以下简称"通程实业"）持 有本行股份 154,109,218 股，占本行总股本比例 3.83%。其一致行动 人长沙通程控股股份有限公司（以下简称"通程控股"）持有本行股 份 123,321,299 股，占本行总股本比例 3.07%，二者合计持股比例为 6.90%。 本次解除质押及质押后，通程实业累计质押其持有的本行股份 75,100,000 股（含本次），通程控股未质押其持有的本行股份，二 者合计质押股份占其合计持股数量比例 27.07%，占本行总股本比例 1.87%。 二、股份质押情况 1.本次股份质押的基本情况 | 实业 | | 通程 | | | 名称 | | 股东 | | | | --- | --- | --- | --- | --- | --- | -- ...

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

Group 1: Monetary Policy and Financial Regulation - The central bank conducted a 7-day reverse repurchase operation of 220.5 billion yuan, resulting in a net withdrawal of 21.5 billion yuan due to 242 billion yuan maturing [1] - The LPR (Loan Prime Rate) remained stable at 3.0% for 1-year and 3.5% for 5-year loans, with expectations of potential downward adjustments in the second half of the year to stimulate demand [3] - The Financial Regulatory Authority highlighted that foreign banks and insurance institutions have total assets exceeding 7 trillion yuan, indicating a positive growth trend in foreign financial institutions in China [6] Group 2: Financial Center Development - The action plan to support the construction of Shanghai as an international financial center aims to enhance the functions of financial services and attract more foreign financial institutions [2] - The 2025 Lujiazui Forum emphasized the importance of financial openness and cooperation for high-quality development, with the central bank announcing eight policy measures to enhance financial services in Shanghai [5] - The "dual-city effect" in Beijing is facilitating the deep integration of foreign banks into the local market, enhancing their operational capabilities and confidence [4] Group 3: Cross-Border Payment Systems - The successful launch of the cross-border payment service in Shenzhen marks a significant milestone in the seamless connection between the mainland and Hong Kong payment systems, allowing real-time remittance services [7][8] - This service is designed to facilitate three main scenarios: remittances from mainland residents to Hong Kong, from Hong Kong residents to the mainland, and bilateral RMB payments between individuals and institutions [8] Group 4: Company-Specific Developments - Changsha Bank's fourth-largest shareholder announced plans to reduce holdings by up to 37 million shares, representing 0.92% of total equity, amid declining revenue and profit growth rates [9] - Despite the bank's asset and liability growth, its operating income and net profit growth have reached new lows since its listing, indicating potential challenges ahead [9]

银行板块短线跳水，长沙银行（601577）、苏农银行（603323）跌超2%，中信银行（601998）、西安 银行（600928）、齐鲁银行（601665）、青岛银行（002948）纷纷下挫。 ...

证券代码：601577 证券简称：长沙银行 公告编号：2025-035 优先股代码：360038 优先股简称：长银优 1 拟减持原因 自身资金需求 预披露期间，若本行股票发生停牌情形的，实际开始减持的时间 根据停牌时间相应顺延。 (一)相关股东是否有其他安排 □是 √否 (二)大股东及董监高此前对持股比例、持股数量、持股期限、减 持方式、减持数量、减持价格等是否作出承诺 □是 √否 (三)本所要求的其他事项 无。 长沙银行股份有限公司 股东减持股份计划公告 本行董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 重要内容提示： ? 股东持股的基本情况：截至本公告披露日，本次计划减持主体 为湖南三力信息技术有限公司，与其一致行动人湖南省通信产业服务 有 限 公 司 共 持 有 长 沙 银 行 股 份 有 限 公 司 （ 简 称 " 本 行 "） 股 份 有限公司持有本行股份 176,262,294 股，占本行总股本的 4.38%；湖 南省通信产业服务有限公司持有本行股份 325,206,010 股，占本行总 股本的 8.09% ...

证券代码：601577 证券简称：长沙银行 公告编号：2025-035 优先股代码：360038 优先股简称：长银优 1 长沙银行股份有限公司 股东减持股份计划公告 本行董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责 任。 1 | | 董事、监事和高级管理人员 | | □是 √否 | | | --- | --- | --- | --- | --- | | | 其他：直接持股 | 5%以下，但与一致行动人合计持股 | | 5%以上 | | 持股数量 | 176,262,294股 | | | | | 持股比例 | 4.38% | | | | | 当前持股股份来源 | IPO 前取得：176,262,294股 | | | | 上述减持主体存在一致行动人： 重要内容提示： 股东持股的基本情况：截至本公告披露日，本次计划减持主体 为湖南三力信息技术有限公司，与其一致行动人湖南省通信产业服务 有限公司共持有长沙银行股份有限公司（简称"本行"）股份 501,468,304 股，占本行总股本的 12.47%。其中，湖南三力信息技术 有限公司持 ...

长沙银行（601577）公告，股东湖南三力信息技术有限公司拟在公告披露之日起15个交易日后的三个月 内，通过集中竞价方式减持不超过3700万股，占公司总股本的0.92%。减持原因为自身资金需求。湖南 三力信息技术有限公司及其一致行动人湖南省通信产业服务有限公司共持有长沙银行12.47%股份，全 部为IPO前取得。 ...

Core Points - The board of directors of Changsha Bank held its first temporary meeting of the eighth session on June 19, 2025, to discuss several key proposals [1][2] - The meeting was attended by 6 out of 7 directors, with one director authorizing another to vote on their behalf [1] - All proposals discussed were approved unanimously, indicating strong consensus among the board members [2] Proposal Summaries - The proposal to abolish the supervisory board office was approved with 7 votes in favor [2] - The asset disposal plan for the year 2025 was also approved with 7 votes in favor, having been reviewed by the risk control and related party transaction committee [2] - The proposal regarding the pledge of shares by a major shareholder, Changsha Tongcheng Industrial (Group) Co., Ltd., was approved with 6 votes in favor, with one director abstaining due to conflict of interest [2] - The proposal to change the expected credit loss model parameters was approved with 7 votes in favor, also having been reviewed by the risk control and related party transaction committee [2] - The meeting included a report on regulatory documents from the Hunan Regulatory Bureau of the National Financial Supervision Administration and discussed the rectification situation [2]

证券代码：601577 证券简称：长沙银行 编号：2025-034 优先股代码：360038 优先股简称：长银优 1 长沙银行股份有限公司 第八届董事会第一次临时会议决议公告 本行董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 长沙银行股份有限公司（简称"本行"）第八届董事会第一次临 时会议于 2025 年 6 月 19 日上午在长沙银行总行 33 楼 3315 会议室以 现场加视频方式召开。会议应出席董事 7 人，实际出席董事 6 人，董 事张曼授权委托董事长赵小中代为行使表决权。郭子嘉女士、王宗润 先生、曹虹剑先生、程青龙先生 4 人待任职资格经监管部门核准后方 可行使表决权。会议由董事长赵小中主持。董事会秘书彭敬恩列席会 议。会议的召开符合《中华人民共和国公司法》《中华人民共和国证 券法》等法律、行政法规、部门规章、规范性文件及《公司章程》的 有关规定，会议所形成的决议合法、有效。 会议对以下议案进行了审议并表决： 一、关于长沙银行股份有限公司撤销监事会办公室的议案 表决情况：同意 7 票，反对 0 票，弃权 0 票。 二、长 ...

长沙银行（601577）首席信息官邬胜表示，长沙银行下阶段将全面落实"做实县域"战略部署，持续推动 资源、人才、服务全面向县域下沉，推动乡村全面振兴、产业全面融合。记者了解到，长沙银行正在构 建"公司+零售+科技"的大县域金融发展体系，打造"一县一特一链"的定制化服务矩阵，以高效金融供给 精准赋能新质生产力发展需求，书写乡村振兴金融篇章。(上证报) ...